Filing summary
Important identity discrepancy: The request identifies TERAWULF INC. and 2016 Q2, but the supplied filing is IKONICS CORPORATION’s unaudited Form 10-Q for the quarter ended June 30, 2016. The figures and commentary below are for IKONICS, not TeraWulf.
Business context and reporting period
IKONICS reported results for the three and six months ended June 30, 2016, compared with the corresponding 2015 periods. Its businesses include Domestic, Export, IKONICS Imaging, Digital Texturing (DTX), and Advanced Material Solutions (AMS). The filing describes AMS as serving aerospace and advanced-material applications. Interim results are unaudited and may not indicate full-year results.
Key financial metrics
| Metric | Q2 2016 | Q2 2015 | Six months 2016 | Six months 2015 |
|---|---|---|---|---|
| Net sales | $4.197 million | $4.654 million | $8.210 million | $8.251 million |
| Gross profit; margin | $1.522 million; 36.3% | $1.640 million; 35.2% | $2.819 million; 34.3% | $2.740 million; 33.2% |
| Operating income (loss) | $49,916 | $194,682 | ($270,390) | ($276,084) |
| Net income (loss) | $39,225 | $27,724 | ($153,587) | ($201,223) |
| Basic and diluted EPS | $0.02 | $0.01 | ($0.08) | ($0.10) |
- Six-month operating cash flow was $528,208, versus $469,418 in 2015. Investing activities used $5.244 million, including $3.399 million for certificates of deposit and $1.844 million for property and equipment. Financing activities provided $3.268 million.
- At June 30, cash and cash equivalents were $800,889; short-term investments were $3.399 million; current assets were $8.500 million and current liabilities $1.123 million. The current ratio was approximately 7.6x.
- The balance sheet reported debt carrying amounts of $125,529 current and $3.141 million long-term. The debt note reports $3.404 million of principal; debt issuance costs reduce the carrying amount. The separate $2.050 million credit line was undrawn.
- Six-month selling, general and administrative expenses were $2.764 million, research and development expenses $324,989, and interest expense $14,999. The six-month income-tax benefit was $129,640.
Material changes versus prior comparable periods
- Q2 sales fell 9.8%, chiefly from lower Export sales (down 28.7%), Domestic sales (down 8.0%), and DTX sales (down substantially). AMS sales rose 137.5% and IKONICS Imaging sales increased 0.9%, partly offsetting declines.
- First-half sales were down 0.5%. Export declined 10.5%, Domestic 5.5%, and DTX 44.0%; AMS grew 117.1% and Imaging grew 12.3%, which management attributed mainly to a new customer.
- Gross margin improved in both comparison periods, which management attributed to sales mix and higher-margin or higher-volume activity in certain segments. SG&A increased as a share of sales, reflecting promotional, trade-show, and export-market selling expenses.
- Operating losses narrowed modestly for the first half, while the company returned to a small net profit in Q2. Q2 2015 R&D included a $46,000 charge for abandoned patent applications; the filing identifies this as a factor in the year-over-year R&D comparison.
- Cash and cash equivalents fell from $2.248 million at year-end 2015 to $801,000, while the company placed $3.399 million in short-term certificates of deposit. The company also recorded new long-term borrowing to fund expansion.
Outlook, management commentary, risks and unusual items
- IKONICS borrowed $3.415 million through tax-exempt industrial revenue bonds to fund a 27,300-square-foot facility expansion and related equipment for AMS. The stated rate is 2.14% (2.77% effective including issuance costs), with monthly payments of approximately $18,000 and maturity in 2041. A mandatory purchase provision applies in 2021. The company reported compliance with the financing covenants at June 30, 2016, including a minimum rolling-four-quarter debt-service coverage ratio of 1.25 to 1.00.
- Management said the AMS expansion was completed in the first half and expected no further significant expansion-project spending. It anticipated approximately $250,000 of additional 2016 capital expenditures, including ERP-system installation and production-capability improvements. No specific revenue or earnings guidance was provided.
- Management described AMS as growing rapidly, cited two long-term aerospace technology agreements and negotiations on a third, and said it would continue investing in R&D, product development, and market expansion. It also noted challenges from a strong U.S. dollar, particularly for international sales.
- Management believed available cash, short-term investments, operating cash flow, debt financing, and the undrawn credit line would support current and anticipated operations. This is management’s assessment, not a guarantee.
- The filing states there were no off-balance-sheet arrangements and no legal proceedings. Management reported effective disclosure controls and no material change in internal control over financial reporting. Forward-looking statements are subject to risks; Part II states “Risk Factors: Not applicable,” while the filing refers readers to risk factors in the company’s prior Form 10-K.
Important facts for investors to verify
- Confirm the filing’s issuer and period: the supplied document is IKONICS’s 2016 Q2 10-Q, not a TeraWulf filing.
- Review the original statements and debt note to reconcile principal outstanding, debt issuance-cost deductions, and current versus long-term classification.
- Track whether AMS growth converts into profitable sales and whether the aerospace agreements and proposed third agreement support management’s outlook.
- Monitor Export and Domestic demand, DTX’s reliance on its largest customer, and the effect of currency strength on international competitiveness.
- Assess liquidity and the debt-service covenant as capital spending, ERP costs, and operating results develop; no numerical forward earnings or revenue guidance is provided.